Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center

Contact
Dean Bajorin, MD
646-422-4333

Jonathan Rosenberg, MD
646-422-4461


Continue Reading

Principal Investigator
Dean Bajorin, MD, Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier
NCT01589094